Insmed Management

Management criteria checks 3/4

Insmed's CEO is Will Lewis, appointed in Sep 2012, has a tenure of 11.5 years. total yearly compensation is $7.79M, comprised of 9.4% salary and 90.6% bonuses, including company stock and options. directly owns 0.29% of the company’s shares, worth $11.61M. The average tenure of the management team and the board of directors is 4.3 years and 9.8 years respectively.

Key information

Will Lewis

Chief executive officer

US$7.8m

Total compensation

CEO salary percentage9.4%
CEO tenure11.5yrs
CEO ownership0.3%
Management average tenure4.3yrs
Board average tenure9.8yrs

Recent management updates

Recent updates

Insmed Incorporated (NASDAQ:INSM) Just Released Its Yearly Results And Analysts Are Updating Their Estimates

Feb 25
Insmed Incorporated (NASDAQ:INSM) Just Released Its Yearly Results And Analysts Are Updating Their Estimates

Insmed Incorporated (NASDAQ:INSM) Investors Are Less Pessimistic Than Expected

Dec 18
Insmed Incorporated (NASDAQ:INSM) Investors Are Less Pessimistic Than Expected

Getting In Cheap On Insmed Incorporated (NASDAQ:INSM) Is Unlikely

Jul 28
Getting In Cheap On Insmed Incorporated (NASDAQ:INSM) Is Unlikely

Calculating The Intrinsic Value Of Insmed Incorporated (NASDAQ:INSM)

Jul 01
Calculating The Intrinsic Value Of Insmed Incorporated (NASDAQ:INSM)

Would Insmed (NASDAQ:INSM) Be Better Off With Less Debt?

Apr 18
Would Insmed (NASDAQ:INSM) Be Better Off With Less Debt?

A Look At The Fair Value Of Insmed Incorporated (NASDAQ:INSM)

Feb 23
A Look At The Fair Value Of Insmed Incorporated (NASDAQ:INSM)

Insmed inks financing agreements to raise $500M

Oct 19

Does Insmed (NASDAQ:INSM) Have A Healthy Balance Sheet?

Oct 17
Does Insmed (NASDAQ:INSM) Have A Healthy Balance Sheet?

An Intrinsic Calculation For Insmed Incorporated (NASDAQ:INSM) Suggests It's 46% Undervalued

Sep 20
An Intrinsic Calculation For Insmed Incorporated (NASDAQ:INSM) Suggests It's 46% Undervalued

Insmed rises 16% on better-than-expected Q2 result

Aug 04

Is Insmed (NASDAQ:INSM) A Risky Investment?

Jun 24
Is Insmed (NASDAQ:INSM) A Risky Investment?

Insmed: Temporarily Stuck

Feb 19

Is Insmed (NASDAQ:INSM) Using Debt Sensibly?

Dec 11
Is Insmed (NASDAQ:INSM) Using Debt Sensibly?

Is Insmed (NASDAQ:INSM) Using Too Much Debt?

Sep 10
Is Insmed (NASDAQ:INSM) Using Too Much Debt?

Estimating The Intrinsic Value Of Insmed Incorporated (NASDAQ:INSM)

Jun 10
Estimating The Intrinsic Value Of Insmed Incorporated (NASDAQ:INSM)

Insmed to raise $250M in stock offering, $500M in notes offering

May 10

We Think The Compensation For Insmed Incorporated's (NASDAQ:INSM) CEO Looks About Right

May 06
We Think The Compensation For Insmed Incorporated's (NASDAQ:INSM) CEO Looks About Right

Is Insmed (NASDAQ:INSM) Weighed On By Its Debt Load?

Apr 06
Is Insmed (NASDAQ:INSM) Weighed On By Its Debt Load?

Have Insiders Been Selling Insmed Incorporated (NASDAQ:INSM) Shares?

Mar 02
Have Insiders Been Selling Insmed Incorporated (NASDAQ:INSM) Shares?

CEO Compensation Analysis

How has Will Lewis's remuneration changed compared to Insmed's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

-US$750m

Sep 30 2023n/an/a

-US$724m

Jun 30 2023n/an/a

-US$696m

Mar 31 2023n/an/a

-US$547m

Dec 31 2022US$8mUS$735k

-US$482m

Sep 30 2022n/an/a

-US$434m

Jun 30 2022n/an/a

-US$416m

Mar 31 2022n/an/a

-US$438m

Dec 31 2021US$7mUS$710k

-US$435m

Sep 30 2021n/an/a

-US$424m

Jun 30 2021n/an/a

-US$375m

Mar 31 2021n/an/a

-US$319m

Dec 31 2020US$6mUS$660k

-US$294m

Sep 30 2020n/an/a

-US$245m

Jun 30 2020n/an/a

-US$242m

Mar 31 2020n/an/a

-US$247m

Dec 31 2019US$7mUS$641k

-US$254m

Sep 30 2019n/an/a

-US$293m

Jun 30 2019n/an/a

-US$320m

Mar 31 2019n/an/a

-US$330m

Dec 31 2018US$6mUS$610k

-US$324m

Sep 30 2018n/an/a

-US$298m

Jun 30 2018n/an/a

-US$256m

Mar 31 2018n/an/a

-US$224m

Dec 31 2017US$4mUS$567k

-US$193m

Compensation vs Market: Will's total compensation ($USD7.79M) is about average for companies of similar size in the US market ($USD6.35M).

Compensation vs Earnings: Will's compensation has increased whilst the company is unprofitable.


CEO

Will Lewis (54 yo)

11.5yrs

Tenure

US$7,789,898

Compensation

Mr. William H. Lewis, also known as Will, J.D., M.B.A., serves as Chairman of Board of Directors of NewAmsterdam Pharma Company N.V. from January, 2024. He has been Chief Executive Officer and President at...


Leadership Team

NamePositionTenureCompensationOwnership
William Lewis
President11.5yrsUS$7.79m0.29%
$ 11.6m
Sara Bonstein
Chief Financial Officer4.2yrsUS$3.43m0.0035%
$ 141.2k
Roger Adsett
Chief Operating Officer4.3yrsUS$4.64m0.040%
$ 1.6m
John Wise
Chief Commercial Officer4.3yrsUS$4.02m0.030%
$ 1.2m
Martina Flammer
Chief Medical Officer4.3yrsUS$3.76m0.0041%
$ 165.3k
Brian Kaspar
Chief Scientific Officerno datano datano data
Eleanor Barisser
Associate Director of Investor Relationsno datano datano data
Michael Smith
Chief Legal Officer & Corporate Secretary2.7yrsno data0.058%
$ 2.3m
Mandy Fahey
Executive Director of Corporate Communicationsno datano datano data
S. Schaeffer
Chief People Strategy Officer11.2yrsUS$2.66m0.025%
$ 993.8k
Eugene Sullivan
Chief Product Strategy Officer6.8yrsUS$1.69mno data
Neil Hughes
GM & Head of Europe4.8yrsno datano data

4.3yrs

Average Tenure

54yo

Average Age

Experienced Management: INSM's management team is considered experienced (4.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
William Lewis
President11.5yrsUS$7.79m0.29%
$ 11.6m
David W. McGirr
Independent Director10.4yrsUS$320.00k0.049%
$ 2.0m
Melvin Sharoky
Independent Director22.8yrsUS$312.50k0.22%
$ 8.7m
Alfred Altomari
Independent Director11.6yrsUS$312.70k0.029%
$ 1.2m
David Brennan
Lead Independent Director9.8yrsUS$342.30k0.064%
$ 2.6m
Clarissa Desjardins
Independent Director4.3yrsUS$315.00k0.024%
$ 961.7k
Elizabeth Anderson
Independent Director5.3yrsUS$310.00k0.029%
$ 1.1m
Leo Lee
Independent Director5.8yrsUS$315.00k0.066%
$ 2.7m
Carol Schafer
Independent Director3.9yrsUS$315.00k0.021%
$ 862.2k

9.8yrs

Average Tenure

64yo

Average Age

Experienced Board: INSM's board of directors are considered experienced (9.8 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.